EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Validation and refinement of the N classification for nasopharyngeal carcinoma based on the 9th version AJCC/UICC TNM staging system in non-endemic regions of China: a multicenter cohort study

Tong Jin, Tong Bu, Bolin Lu, Junyi Liu, Ting Qiu, Changyong He, Dan Zong, Yang Li, Yinsu Zhu, Jianfeng Wu, Shengfu Huang, Jin Gao und 3 weitere

Clinical and Translational Radiation Oncology · 2027-01 · 62 · 101285

DOI: 10.1016/j.ctro.2026.101285 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical and Translational Radiation Oncology, 2027-01. Verfasst von Tong Jin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Rese…. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Development Fund, Jiangsu Cancer Hospital, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The applicability of the ninth version AJCC/UICC N classification for nasopharyngeal carcinoma (NPC) in non-endemic regions remains uncertain, particularly regarding the incorporation of advanced extranodal extension (ENE) into the N3 category. We conducted a retrospective multicenter study including 1356 patients with NPC treated between 2011 and 2021 in eastern China. All patients were staged according to both the eighth and ninth version systems. Survival outcomes, including overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS), and regional recurrence-free survival (RRFS), were analyzed using Kaplan-Meier and Cox regression methods. Model performance was evaluated using the concordance index (C-index) and Akaike information criterion (AIC). Under the ninth version, 136 patients with advanced ENE were upstaged from N1-N2 to N3, resulting in clearer separation between N3 and N0-N2 groups across all endpoints. No statistically significant differences in survival outcomes were observed between patients upstaged to N3 and those with conventional N3 disease. The ninth version showed statistically significant but small increases in C-index compared with the eighth version. However, time-dependent AUC differences varied across survival endpoints and follow-up time points. Within the N3 subgroup, advanced ENE was associated with significantly worse OS, PFS, and DMFS, and remained an independent predictor of OS (HR 1.78, p = 0.032) and DMFS (HR 2.03, p = 0.009). In conclusion, the ninth version N classification showed modest incremental prognostic performance in this non-endemic cohort, driven primarily by the identification of high-risk N3 disease. These findings support the staging relevance of advanced ENE, although prospective validation incorporating additional clinical and biological predictors remains necessary.

Schlagwörter

Stichwörter der Autor:innen

AJCC/UICC stagingMulticenter retrospective studyN classificationNasopharyngeal carcinomaNon-endemic region

Autor:innen und Institutionen

  • Department of Radiation Oncology, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing 210009, China.
  • Department of Radiation Oncology, Jiangsu Key Laboratory of Innovative Cancer Diagnosis& Therapeutics, Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/The Affiliated Cancer Hospital of Nanjing Medical Unive…
  • Department of Radiology, Nanjing Medical University Affiliated Cancer Hospital, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing 210009, China.
  • Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230000, China.
  • Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310000, China.

Förderung

  • Science and Technology Development Fund
  • Jiangsu Cancer Hospital
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Jin, T., Bu, T., Lu, B., Liu, J., Qiu, T., He, C., Zong, D., Li, Y., Zhu, Y., Wu, J., Huang, S., Gao, J., Chen, X., Wu, L., & He, X. (2027). Validation and refinement of the N classification for nasopharyngeal carcinoma based on the 9th version AJCC/UICC TNM staging system in non-endemic regions of China: a multicenter cohort study. Clinical and Translational Radiation Oncology, 62, 101285. https://doi.org/10.1016/j.ctro.2026.101285

Vancouver

Jin T, Bu T, Lu B, Liu J, Qiu T, He C, et al. Validation and refinement of the N classification for nasopharyngeal carcinoma based on the 9th version AJCC/UICC TNM staging system in non-endemic regions of China: a multicenter cohort study. Clinical and Translational Radiation Oncology. 2027;62:101285. doi:10.1016/j.ctro.2026.101285

BibTeX
@article{Jin2027,
  author = {Jin, Tong and Bu, Tong and Lu, Bolin and Liu, Junyi and Qiu, Ting and He, Changyong and Zong, Dan and Li, Yang and Zhu, Yinsu and Wu, Jianfeng and Huang, Shengfu and Gao, Jin and Chen, Xiaozhong and Wu, Lirong and He, Xia},
  title = {Validation and refinement of the N classification for nasopharyngeal carcinoma based on the 9th version AJCC/UICC TNM staging system in non-endemic regions of China: a multicenter cohort study},
  journal = {Clinical and Translational Radiation Oncology},
  year = {2027},
  volume = {62},
  pages = {101285},
  doi = {10.1016/j.ctro.2026.101285}
}
Kostenlos starten →